Insider · CIK 0001726096

Daniell Richard

Reports to the SEC for 1 company · TEL AVIV

sec.gov

Transactions

Companies

Filings

CIK

0001726096

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Europe Commercial	SSale	−30K sh	$35.40	−$1.06M	55,755
2026-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	−17.3K sh	—	—	51,887
2026-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Europe Commercial	SSale	−17.3K sh	$31.67	−$548K	85,755
2026-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	+17.3K sh	—	—	103,050
2026-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Europe Commercial	SSale	−20.5K sh	$32.46	−$664K	123,127
2026-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	−33.5K sh	—	—	0
2026-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	+33.5K sh	—	—	156,639
2026-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	−20.5K sh	—	—	40,923
2026-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Europe Commercial	SSale	−33.5K sh	$32.46	−$1.09M	123,127
2026-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	+20.5K sh	—	—	143,588
2026-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	EVP, Europe Commercial	AAward	+33.4K sh	—	—	33,424
2026-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Europe Commercial	SSale	−37.4K sh	$32.95	−$1.23M	85,755
2026-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	−62.3K sh	—	—	62,253
2026-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Europe Commercial	SSale	−66.7K sh	$32.36	−$2.16M	123,127
2026-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	+141K sh	—	—	189,862
2026-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	+62.3K sh	—	—	110,634
2026-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	−141K sh	—	—	0
2026-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Europe Commercial	SSale	−62.3K sh	$32.36	−$2.01M	48,384
2026-01-27	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	EVP, Europe Commercial	AAward	+141K sh	—	—	141,478
2025-12-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Options (right to buy)M Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	−15K sh	—	—	0
2025-12-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Europe Commercial	SSale	−115K sh	$28.68	−$3.31M	48,384
2025-12-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	+15K sh	$16.99	+$255K	163,852
2025-12-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Options (right to buy)M Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	−100K sh	—	—	0
2025-12-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	+100K sh	$18.61	+$1.87M	148,841
2025-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	+22.6K sh	—	—	119,345
2025-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Europe Commercial	SSale	−11.6K sh	$15.91	−$185K	0
2025-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Europe Commercial	SSale	−22.6K sh	$15.91	−$359K	96,769
2025-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	−22.6K sh	—	—	0
2025-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Europe Commercial	SSale	−30K sh	$15.91	−$478K	96,769
2025-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Europe Commercial	SSale	−7,108 sh	$15.91	−$113K	0
2025-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	EVP, Europe Commercial	AAward	+69.2K sh	—	—	69,182
2025-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Europe Commercial	SSale	−48.4K sh	$15.90	−$769K	48,384
2025-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Europe Commercial	SSale	−21.9K sh	$15.73	−$344K	11,641
2025-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Europe Commercial	SSale	−56.4K sh	$15.73	−$887K	126,784
2025-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	−20.5K sh	—	—	61,384
2025-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Europe Commercial	SSale	−12.9K sh	$15.56	−$201K	0
2025-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	+183K sh	—	—	183,169
2025-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	−33.5K sh	—	—	33,512
2025-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	+33.5K sh	—	—	33,512
2025-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	+20.5K sh	—	—	20,461
2025-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Europe Commercial	SSale	−13.4K sh	$15.73	−$210K	7,108
2025-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	−183K sh	—	—	0
2025-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	+62.3K sh	—	—	62,250
2025-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	−62.3K sh	—	—	124,503
2025-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Europe Commercial	SSale	−49.3K sh	$16.19	−$798K	12,936
2025-01-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	EVP, Europe Commercial	AAward	+183K sh	—	—	183,169
2024-08-12	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Europe Commercial	SSale	−98.9K sh	$17.30	−$1.71M	0
2024-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	−22.6K sh	—	—	22,576
2024-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Europe Commercial	SSale	−26.1K sh	$13.52	−$352K	98,943
2024-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Europe Commercial	MExercise/Conversion	+55.2K sh	—	—	124,996

Recent filings

Accepted (ET)
May 74
Daniell Richard0001193125-26-211833
SEC(opens sec.gov)
Mar 94
Daniell Richard0001193125-26-098512
SEC(opens sec.gov)
Mar 64
Daniell Richard0001193125-26-096584
SEC(opens sec.gov)
Mar 54
Daniell Richard0001193125-26-093945
SEC(opens sec.gov)
Jan 294
Daniell Richard0001193125-26-029306
SEC(opens sec.gov)
Dec 114
Daniell Richard0001193125-25-315938
SEC(opens sec.gov)

Companies

TEVA PHARMACEUTICAL INDUSTRIES LTDEVP, Europe CommercialTEVA

Address

C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A ST.,

TEL AVIV, 6944020